Prevalence of multidrug-resistant and extensively drug-resistant tuberculosis in patients with pulmonary tuberculosis in zahedan, southeastern iran.
作者信息
Metanat M, Sharifi-Mood B, Shahreki Sh, Dawoudi S H
机构信息
Research Center for Infectious Diseases and Tropical Medicine, Zahedan University of Medical sciences, Zahedan, Iran.
出版信息
Iran Red Crescent Med J. 2012 Jan;14(1):53-5. Epub 2012 Jan 1.
Abstract
摘要
相似文献
1
Prevalence of multidrug-resistant and extensively drug-resistant tuberculosis in patients with pulmonary tuberculosis in zahedan, southeastern iran.
Iran Red Crescent Med J. 2012 Jan;14(1):53-5. Epub 2012 Jan 1.
2
High Rates of Treatment Success in Pulmonary Multidrug-Resistant Tuberculosis by Individually Tailored Treatment Regimens.
Ann Am Thorac Soc. 2016 Aug;13(8):1271-8. doi: 10.1513/AnnalsATS.201512-845OC.
3
Haarlem 3 is the predominant genotype family in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in the capital of Iran: A 5-year survey.
J Glob Antimicrob Resist. 2016 Jun;5:7-10. doi: 10.1016/j.jgar.2016.01.007. Epub 2016 Feb 26.
4
Prevalence of and risk factors for multidrug-resistant tuberculosis in Iran and its neighboring countries: systematic review and meta-analysis.
Rev Soc Bras Med Trop. 2017 May-Jun;50(3):287-295. doi: 10.1590/0037-8682-0002-2017.
5
Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran.
Clin Infect Dis. 2006 Oct 1;43(7):841-7. doi: 10.1086/507542. Epub 2006 Aug 21.
6
Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran.
Microb Drug Resist. 2010 Mar;16(1):81-6. doi: 10.1089/mdr.2009.0073.
7
Antituberculosis Drug Resistance in Pulmonary Isolates of Mycobacterium tuberculosis, Cuba 2012-2014.
MEDICC Rev. 2017 Jan;19(1):10-15. doi: 10.37757/MR2017.V19.N1.3.
8
Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.
9
Pharmacokinetic Modeling, Simulation, and Development of a Limited Sampling Strategy of Cycloserine in Patients with Multidrug-/Extensively Drug-Resistant Tuberculosis.
Clin Pharmacokinet. 2020 Jul;59(7):899-910. doi: 10.1007/s40262-020-00860-8.
10
HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
J Indian Med Assoc. 2009 May;107(5):281-2, 284-6.
引用本文的文献
1
Epidemiology of first- and second-line drugs-resistant pulmonary tuberculosis in Iran: Systematic review and meta-analysis.
J Clin Tuberc Other Mycobact Dis. 2024 Mar 16;35:100430. doi: 10.1016/j.jctube.2024.100430. eCollection 2024 May.
2
Drug Resistance to Anti-Tuberculosis Drugs: A Cross-Sectional Study From Makkah, Saudi Arabia.
Cureus. 2021 Aug 10;13(8):e17069. doi: 10.7759/cureus.17069. eCollection 2021 Aug.
3
Prevalence and Determinants of Multidrug-Resistant Tuberculosis in Makkah, Saudi Arabia.
Infect Drug Resist. 2020 Nov 10;13:4031-4038. doi: 10.2147/IDR.S277477. eCollection 2020.
4
Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia.
Can J Infect Dis Med Microbiol. 2019 Sep 9;2019:2923549. doi: 10.1155/2019/2923549. eCollection 2019.
5
Emerging and re-emerging infectious diseases in Iran.
Iran J Microbiol. 2017 Jun;9(3):122-142.
6
Low Levels of Extensively Drug-resistant Tuberculosis among Multidrug Resistant Tuberculosis Isolates and Their Relationship to Risk Factors: Surveillance in Tehran, Iran; 2006 to 2014.
Osong Public Health Res Perspect. 2017 Apr;8(2):116-123. doi: 10.24171/j.phrp.2017.8.2.03. Epub 2017 Apr 30.
7
Determining the Risk of Intra-Community Transmission of Tuberculosis in the Northwest of Iran Through 15 Loci Miru-Vntr Typing.
Eur J Microbiol Immunol (Bp). 2017 Feb 27;7(1):46-54. doi: 10.1556/1886.2016.00033. eCollection 2017 Mar.
8
Prevalence of Multidrug Resistant Pulmonary Tuberculosis in North Bihar.
J Clin Diagn Res. 2015 Nov;9(11):LC09-12. doi: 10.7860/JCDR/2015/14024.6793. Epub 2015 Nov 1.
9
Epidemiological Characterization of Drug Resistance among Mycobacterium tuberculosis Isolated from Patients in Northeast of Iran during 2012-2013.
Biomed Res Int. 2015;2015:747085. doi: 10.1155/2015/747085. Epub 2015 May 3.
本文引用的文献
1
First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Int J Infect Dis. 2009 Sep;13(5):e236-40. doi: 10.1016/j.ijid.2008.11.027. Epub 2009 Mar 13.
2
Extensively drug-resistant tuberculosis in california, 1993-2006.
Clin Infect Dis. 2008 Aug 15;47(4):450-7. doi: 10.1086/590009.
3
Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
Clin Infect Dis. 2007 Dec 1;45(11):1409-14. doi: 10.1086/522987. Epub 2007 Oct 22.
4
Worldwide emergence of extensively drug-resistant tuberculosis.
Emerg Infect Dis. 2007 Mar;13(3):380-7. doi: 10.3201/eid1303.061400.
5
Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control.
Wkly Epidemiol Rec. 2006 Nov 10;81(45):430-2.
6
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.
Lancet. 2006 Nov 4;368(9547):1575-80. doi: 10.1016/S0140-6736(06)69573-1.
7
Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran.
Clin Infect Dis. 2006 Oct 1;43(7):841-7. doi: 10.1086/507542. Epub 2006 Aug 21.
8
Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.
MMWR Morb Mortal Wkly Rep. 2006 Mar 24;55(11):301-5.
9
Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran.
Int J Infect Dis. 2005 Nov;9(6):317-22. doi: 10.1016/j.ijid.2004.09.012. Epub 2005 Sep 23.
10
Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs.
Eur J Clin Microbiol Infect Dis. 2005 Mar;24(3):202-6. doi: 10.1007/s10096-005-1284-z.
Zotero 插件